CN102190569B - Method for preparing Prasugrel intermediate alpha-cyclopropylcarbonyl-2-fluorobenzyl bromide - Google Patents

Method for preparing Prasugrel intermediate alpha-cyclopropylcarbonyl-2-fluorobenzyl bromide Download PDF

Info

Publication number
CN102190569B
CN102190569B CN201010134912.XA CN201010134912A CN102190569B CN 102190569 B CN102190569 B CN 102190569B CN 201010134912 A CN201010134912 A CN 201010134912A CN 102190569 B CN102190569 B CN 102190569B
Authority
CN
China
Prior art keywords
hours
cyclopropyl
benzyl bromide
water
fluoro benzyl
Prior art date
Application number
CN201010134912.XA
Other languages
Chinese (zh)
Other versions
CN102190569A (en
Inventor
王立新
周勇
徐小英
唐鹤
黄青春
蒋君慧
Original Assignee
浙江海翔药业股份有限公司
中国科学院成都有机化学有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 浙江海翔药业股份有限公司, 中国科学院成都有机化学有限公司 filed Critical 浙江海翔药业股份有限公司
Priority to CN201010134912.XA priority Critical patent/CN102190569B/en
Publication of CN102190569A publication Critical patent/CN102190569A/en
Application granted granted Critical
Publication of CN102190569B publication Critical patent/CN102190569B/en

Links

Abstract

The invention discloses a new method for preparing a Prasugrel intermediate alpha-cyclopropylcarbonyl-2-fluorobenzyl bromide which is a compound shown as a formula (III). In the method, a compound shown as a formula (I), namely cyclopropyl-2-fluorobenzyl ketone is taken as a raw material, and is bromized by a compound show as a formula (II), namely phenyltrimethylammonium tribromide to form the target product of alpha-cyclopropylcarbonyl-2-fluorobenzyl bromide, namely the compound in the formula (III). The method has the advantages of mild reaction conditions, high selectivity, high yield, low cost and environmental friendliness, and is suitable for large-scale industrial production.

Description

A kind of preparation method of Prasugrel intermediate alpha-cyclopropylcarbonyl-2-fluorobenzyl bromide
Technical field
The invention belongs to field of medicine and chemical technology, be specifically related to the preparation method of Prasugrel intermediate alpha-cyclopropylcarbonyl-2-fluorobenzyl bromide.
Background technology
Prasugrel is and the similar tetrahydrothieno pyridines compounds of clopidogrel, has the advantages such as platelet aggregation restraining effect, good oral absorptivity, stronger metabolic activity and toxicity is weak.Clinical three phases demonstrate the activity, tolerance and the security that are better than clopidogrel, are therefore a kind of rising antithrombotic reagents.
At present about the preparation method of prasugrel mainly contains EP192535, EP542411, US4740510, US5288726, US5874581, WO04098713, CN101250193, CN92111584, CN10117743 etc.In these all disclosed methods, α-cyclopropyl carbonyl-2-fluoro benzyl bromide (formula compound III) be one prepare prasugrel must obligato important intermediate.
In current published patent, the preparation of α-cyclopropyl carbonyl-2-fluoro benzyl bromide is all to adopt bromine or N-bromo-succinimide (NBS) to make brominated reagent, bromine can produce a large amount of Hydrogen bromides, NBS also can use bromine in the process of recycling, also exist selectivity lower simultaneously, product yield is low, cost is high, bromine is difficult for the shortcomings such as circulation is reclaimed, product purity is not high, separation and purification is difficult, and it is many unfavorable that this just causes above-mentioned two kinds of brominated reagents to exist at aspects such as operational safety, environmental protection, economy.
Summary of the invention
For above technological deficiency, the invention provides the preparation method of a kind of prasugrel key intermediate formula (III) compound α-cyclopropyl carbonyl-2-fluoro benzyl bromide, described method comprises:
In organic solvent, formula (I) compound 1-cyclopropyl base-2-(2-fluorophenyl) ethyl ketone reacts at-40 ℃~60 ℃ with formula (II) compound, obtains formula (III) compound α-cyclopropyl carbonyl-2-fluoro benzyl bromide
In preparation method of the present invention, described organic solvent includes but not limited in anhydrous diethyl ether, methyl tertiary butyl ether, isopropyl ether, tetrahydrofuran (THF), methylene dichloride, ethylene dichloride, chloroform, acetone, butanone, hexone, toluene, dimethylbenzene, chlorinated benzene, ethyl acetate, butylacetate, dioxane, acetonitrile, methyl alcohol, ethanol, Virahol, propyl carbinol, DMF, DEF, DMSO or DME or they mixture arbitrarily; Described organic solvent is tetrahydrofuran (THF) or anhydrous diethyl ether more preferably.
In preparation method of the present invention, as one of preferred embodiment, the consumption of described organic solvent is calculated as 1~50ml by every 1g formula (I) compound, and further preferably the consumption of organic solvent is that every 1g formula (I) compound is calculated as 15~20ml.
The temperature of reaction of described bromo-reaction, those skilled in the art can adopt this area routine according to the difference of solvent, are generally-40 ℃~60 ℃, are preferably 5 ℃~10 ℃.
In preparation method of the present invention, the mol ratio of described formula (I) compound and formula (II) compound is 0.8: 1-1.5: 1, and further preferred 1.00-1.10; Further be preferably 1.05: 1.
In the inventive method, those skilled in the art can select different feeding modes according to the organic solvent difference with reaction, in the time selecting haloalkane, alcohol, ester to make solvent, the mode that described formula (I) compound and formula (II) compound react is: first formula is dissolved in (I) compound in organic solvent, then disposable or point 10-20 equal portions join formula (II) compound to contain in formula (I) compound solvent in batches and react, preferably 30 minutes~6 hours reaction times;
In the time selecting other organic solvent, the mode that described formula (I) compound and formula (II) compound react is: first in formula (I) compound, be dissolved in the organic solvent that accounts for total organic solvent amount 30%-40%, and formula (II) compound is dissolved in residual solvent, then be added dropwise in the organic solvent that contains formula (I) compound and react containing formula (II) compound organic solvent, take under the condition of the mode that drips preferably 30 minutes~2 hours reaction times after dropwising.
The invention provides that a kind of selectivity is good, yield is high, the method for environmental friendliness, with low cost and applicable industrially producing alpha-cyclopropyl carbonyl-2-fluoro benzyl bromide (III).
Embodiment
Now further illustrate the present invention by following examples, but protection scope of the present invention is not limited in this.
Embodiment 1
20g (0.112mol) cyclopropyl-2-luorobenzyl ketone is dissolved in 100mlTHF, stir lower 5 ℃ of left and right and be slowly added dropwise to tribromide phenyl TMA (TriMethylAmine) (PTT) 40g (0.1064mol) that 200ml tetrahydrofuran (THF) (THF) dissolves, there is gradually solid to separate out, within approximately 10 hours, dropwise, after dropwising, continue to maintain 5 ℃-10 ℃ reactions 2 hours, after reaction stops, in reaction solution, add 100ml water, at 30 ℃, most of THF is reclaimed in underpressure distillation, debris 100ml, the extraction of 50ml ethyl acetate, merge organic layer, and with the water washing of 3 × 50ml saturated common salt, anhydrous sodium sulfate drying, the desolventizing of reducing pressure at 40 ℃, obtain α-cyclopropyl carbonyl-2-fluoro benzyl bromide crude product 28.3g, yield 97.9%, HPLC:> 94%.
1H?NMR(CDCl 3)δppm:0.93-1.04(2H,m),1.11-1.19(2H,m),2.11-2.17(2H,m),5.96(1H,s),7.05-7.49(2H,m).
Mass spectrum (Cl, m/z): 259 (M ++ 1).
Embodiment 2
Substitute tetrahydrofuran (THF) with anhydrous diethyl ether, other reactions steps, with embodiment 1, reacts complete, in reaction solution, add 100ml water, after layering, water layer 50ml extracted with diethyl ether, merges organic layer, and with the water washing of 3 × 50ml saturated common salt, anhydrous sodium sulfate drying, the desolventizing of reducing pressure at 40 ℃, obtains α-cyclopropyl carbonyl-2-fluoro benzyl bromide crude product 27.8g, yield 96.2%, HPLC:> 94.5%.
Embodiment 3
20g (0.112mol) cyclopropyl-2-luorobenzyl ketone is dissolved in 300ml methylene dichloride, stir lower 10 ℃ of left and right small quantities of tribromide phenyl TMA (TriMethylAmine) (PTT) 40g (0.1064mol) several times, the reddish-brown dissolution of solid adding before this, then adularescent solid is separated out gradually, within approximately 8 hours, add, continue to maintain about 10 ℃ reactions 2 hours, after reaction stops, in reaction solution, add 100ml water, after layering, water layer 50ml dichloromethane extraction, merge organic layer, and with the water washing of 3 × 50ml saturated common salt, anhydrous sodium sulfate drying, the desolventizing of reducing pressure at 40 ℃, obtain α-cyclopropyl carbonyl-2-fluoro benzyl bromide crude product 28g, yield 96.9%, HPLC:> 93.5%.
Embodiment 4
20.8g (0.117mol) cyclopropyl-2-luorobenzyl ketone is dissolved in 100ml toluene, stir lower 5 ℃ of left and right and be slowly added dropwise to tribromide phenyl TMA (TriMethylAmine) (PTT) 40g (0.1064mol) that 200ml toluene dissolves, there is gradually solid to separate out, within approximately 10 hours, dropwise, after dropwising, continue to maintain 5 ℃-10 ℃ reactions 2 hours, after reaction stops, in reaction solution, add 100ml water, after layering, 50ml toluene extraction for water layer, merge organic layer, and with the water washing of 3 × 50ml saturated common salt, anhydrous sodium sulfate drying, the desolventizing of reducing pressure at 40 ℃, obtain α-cyclopropyl carbonyl-2-fluoro benzyl bromide crude product 27.3g, yield 94.5%, HPLC:> 92.6%.

Claims (4)

1. a preparation method for intermediate α-cyclopropyl carbonyl-2-fluoro benzyl bromide of prasugrel, is characterized in that, described method comprises:
20g cyclopropyl-2-luorobenzyl ketone is dissolved in 100ml tetrahydrofuran (THF), stir lower 5 ℃ and be slowly added dropwise to the tribromide phenyl TMA (TriMethylAmine) 40g that 200ml tetrahydrofuran (THF) dissolves, there is gradually solid to separate out, within 10 hours, dropwise, after dropwising, continue to maintain 5 ℃-10 ℃ reactions 2 hours, after reaction stops, in reaction solution, add 100ml water, at 30 ℃, most of THF is reclaimed in underpressure distillation, debris 100ml, the extraction of 50ml ethyl acetate, merge organic layer, and with the water washing of 3 × 50ml saturated common salt, anhydrous sodium sulfate drying, the desolventizing of reducing pressure at 40 ℃, obtain α-cyclopropyl carbonyl-2-fluoro benzyl bromide crude product 28.3g, yield 97.9%, HPLC:>94%,
1H?NMR(CDCl 3)δppm:0.93-1.04(2H,m),1.11-1.19(2H,m),2.11-2.17(2H,m),5.96(1H,s),7.05-7.49(2H,m);
Mass spectrum (Cl, m/z): 259(M ++ 1).
2. a preparation method for intermediate α-cyclopropyl carbonyl-2-fluoro benzyl bromide of prasugrel, is characterized in that, described method comprises:
20g cyclopropyl-2-luorobenzyl ketone is dissolved in 100ml anhydrous diethyl ether, stir lower 5 ℃ and be slowly added dropwise to the tribromide phenyl TMA (TriMethylAmine) 40g that 200ml anhydrous diethyl ether dissolves, there is gradually solid to separate out, within 10 hours, dropwise, after dropwising, continue to maintain 5 ℃-10 ℃ reactions 2 hours, after reaction stops, in reaction solution, add 100ml water, after layering, water layer 50ml extracted with diethyl ether, merge organic layer, and with the water washing of 3 × 50ml saturated common salt, anhydrous sodium sulfate drying, the desolventizing of reducing pressure at 40 ℃, obtain α-cyclopropyl carbonyl-2-fluoro benzyl bromide crude product 27.8g, yield 96.2%, HPLC:>94.5%.
3. a preparation method for intermediate α-cyclopropyl carbonyl-2-fluoro benzyl bromide of prasugrel, is characterized in that, described method comprises:
20g cyclopropyl-2-luorobenzyl ketone is dissolved in 300ml methylene dichloride, stir lower 10 ℃ of small quantities of tribromide phenyl TMA (TriMethylAmine) 40g several times, the reddish-brown dissolution of solid adding before this, then adularescent solid is separated out gradually, within 8 hours, add, continue to maintain 10 ℃ of reactions 2 hours, after reaction stops, in reaction solution, add 100ml water, after layering, water layer 50ml dichloromethane extraction, merge organic layer, and with the water washing of 3 × 50ml saturated common salt, anhydrous sodium sulfate drying, the desolventizing of reducing pressure at 40 ℃, obtain α-cyclopropyl carbonyl-2-fluoro benzyl bromide crude product 28g, yield 96.9%, HPLC:>93.5%.
4. a preparation method for intermediate α-cyclopropyl carbonyl-2-fluoro benzyl bromide of prasugrel, is characterized in that, described method comprises:
20.8g cyclopropyl-2-luorobenzyl ketone is dissolved in 100ml toluene, stir lower 5 ℃ and be slowly added dropwise to the tribromide phenyl TMA (TriMethylAmine) 40g that 200ml toluene dissolves, there is gradually solid to separate out, within 10 hours, dropwise, after dropwising, continue to maintain 5 ℃-10 ℃ reactions 2 hours, after reaction stops, in reaction solution, add 100ml water, after layering, 50ml toluene extraction for water layer, merge organic layer, and with the water washing of 3 × 50ml saturated common salt, anhydrous sodium sulfate drying, the desolventizing of reducing pressure at 40 ℃, obtain α-cyclopropyl carbonyl-2-fluoro benzyl bromide crude product 27.3g, yield 94.5%, HPLC:>92.6%.
CN201010134912.XA 2010-03-12 2010-03-12 Method for preparing Prasugrel intermediate alpha-cyclopropylcarbonyl-2-fluorobenzyl bromide CN102190569B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201010134912.XA CN102190569B (en) 2010-03-12 2010-03-12 Method for preparing Prasugrel intermediate alpha-cyclopropylcarbonyl-2-fluorobenzyl bromide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010134912.XA CN102190569B (en) 2010-03-12 2010-03-12 Method for preparing Prasugrel intermediate alpha-cyclopropylcarbonyl-2-fluorobenzyl bromide

Publications (2)

Publication Number Publication Date
CN102190569A CN102190569A (en) 2011-09-21
CN102190569B true CN102190569B (en) 2014-07-02

Family

ID=44599535

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201010134912.XA CN102190569B (en) 2010-03-12 2010-03-12 Method for preparing Prasugrel intermediate alpha-cyclopropylcarbonyl-2-fluorobenzyl bromide

Country Status (1)

Country Link
CN (1) CN102190569B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012153348A2 (en) * 2011-05-09 2012-11-15 Glenmark Generics Limited Process for preparation of prasugrel and its intermediates
CN102643180B (en) * 2012-03-23 2015-04-15 广东药学院 Preparation method of 2-halogenated-2-(2-fluorophenyl)-1-cyclopropylethanone

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101177430A (en) * 2007-12-11 2008-05-14 鲁南制药集团股份有限公司 Hydrogenated pyridine derivative and method for preparing salt thereof
CN101234963A (en) * 2008-03-05 2008-08-06 江苏八巨药业有限公司 Industrial synthesis technique for DL-naproxen
WO2009062044A2 (en) * 2007-11-09 2009-05-14 Dr. Reddy's Laboratories Ltd. Processes for the preparation of prasugrel, and its salts and polymorphs
CN101486635A (en) * 2009-02-27 2009-07-22 上海医药工业研究院 Preparation of alpha-cyclopropyl carbonyl-2-benzyl-fluorobenzyl halogen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI392681B (en) * 2006-04-06 2013-04-11 Daiichi Sankyo Co Ltd Prasugrel with high purity and a method for preparing its acid addition salt

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009062044A2 (en) * 2007-11-09 2009-05-14 Dr. Reddy's Laboratories Ltd. Processes for the preparation of prasugrel, and its salts and polymorphs
CN101177430A (en) * 2007-12-11 2008-05-14 鲁南制药集团股份有限公司 Hydrogenated pyridine derivative and method for preparing salt thereof
CN101343278A (en) * 2007-12-11 2009-01-14 鲁南制药集团股份有限公司 Preparation method for hydrogenated pyridine derivant and its salt
CN101234963A (en) * 2008-03-05 2008-08-06 江苏八巨药业有限公司 Industrial synthesis technique for DL-naproxen
CN101486635A (en) * 2009-02-27 2009-07-22 上海医药工业研究院 Preparation of alpha-cyclopropyl carbonyl-2-benzyl-fluorobenzyl halogen

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
[Bmim]Br3对酮的选择性单溴化反应;张胜建 等;《有机化学》;20060518;第26卷(第2期);第236-238页 *
dl-萘普生合成中转位工艺的改进;马英;《中国现代应用药学杂志》;19980831;第15卷(第4期);第40页左栏倒数第5-1行 *
史达清 等.溴代反应中的选择性溴化剂.《化学试剂》.1995,第17卷(第6期),第347页右栏倒数第8-6行.
孙志国 等.普拉格雷的合成.《中国新药工业杂志》.2009,第40卷(第4期),第244-246页.
张胜建 等.[Bmim]Br3对酮的选择性单溴化反应.《有机化学》.2006,第26卷(第2期),第236-238页.
普拉格雷中间体的合成研究;荆亚萍 等;《广东药学院学报》;20090630;第25卷(第3期);第273页右栏倒数第8-1行 *
普拉格雷的合成;孙志国 等;《中国新药工业杂志》;20090615;第40卷(第4期);第244-246页 *
林原斌等 编著.9-070 2-溴-6'-甲氧基-2'-萘乙酮和2,2-二溴-6-甲氧基萘乙酮.《有机中间体的制备第一版》.北京科学出版社,2006,第216页第8-12行. *
林原斌等编著.9-0702-溴-6'-甲氧基-2'-萘乙酮和2 2-二溴-6-甲氧基萘乙酮.《有机中间体的制备第一版》.北京科学出版社
溴代反应中的选择性溴化剂;史达清 等;《化学试剂》;19950325;第17卷(第6期);第347页右栏倒数第8-6行 *
荆亚萍 等.普拉格雷中间体的合成研究.《广东药学院学报》.2009,第25卷(第3期),第273页右栏倒数第8-1行.
马英.dl-萘普生合成中转位工艺的改进.《中国现代应用药学杂志》.1998,第15卷(第4期),第40页左栏倒数第5-1行.

Also Published As

Publication number Publication date
CN102190569A (en) 2011-09-21

Similar Documents

Publication Publication Date Title
EP1740593B1 (en) Processes for the preparation of clopidogrel hydrogen sulfate polymorphic form i
CN100434410C (en) Process of producing pentafluorophenol
CN102046576B (en) Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
CN101792400B (en) Synthetic method for agomelatine
CN105473562A (en) Process for manufacturing 4-propargylated amino-benzoxazinones
CN104496952B (en) Synthesis method of dapagliflozin
CN102311437A (en) Preparation method of platelet-aggregation-resisting medicament Ticagrelor
CN108689968A (en) Two kinds of compounds and preparation method thereof and the purposes in synthesizing Bu Waxitan
CN105263913A (en) Thio-1,2,4-triazole derivatives and method for preparing the same
CN102869646A (en) Preparation of methionine or selenomethionine from homoserine via a lactone intermediate
CN106029658B (en) The method for preparing Diacloden
CN103342704B (en) A kind of preparation method of antithrombotic reagent Eliquis
CN102653533B (en) Total synthesis method of mangostin
Chen et al. An improved synthesis of a key intermediate for (+)-biotin from d-mannose
CN104496979A (en) Method for preparing oxazolidinone compound and intermediate thereof
CN106831737B (en) Preparation of vipatavir and derivatives thereof
CN102485718B (en) Sitagliptin intermediate and its preparation method
CN103508899B (en) Method for preparing ticagrelor key intermediate and racemate thereof and special intermediate for implementing method
EP2176269B1 (en) A method of manufacturing 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7- tetrahydrothieno[3,2-c]pyridin-2-yl acetate (prasugrel)
CN107936029B (en) Method for synthesizing Ribociclib
CN106977572A (en) A kind of method using hyodesoxycholic acid as Material synthesis lithocholic acid
CN105801575A (en) Synthetic method of imidazo[1,2-a]pyridine
TW201831461A (en) Process for preparing apalutamide
CN101565406B (en) Preparation process for cyproconazole
US7456322B2 (en) Process for preparing 1,3-dibromoacetone, 1-3-dichloroacetone and epichlorohydrin

Legal Events

Date Code Title Description
PB01 Publication
C06 Publication
SE01 Entry into force of request for substantive examination
C10 Entry into substantive examination
GR01 Patent grant
C14 Grant of patent or utility model